NVO Investor Relations
Get all historical data on Novo Nordisk
Stop wasting time on manual entry and start making faster, smarter decisions with accurate, up-to-date NVO numbers you can trust.
- Deep dive into the latest Novo Nordisk earnings data, including segmental KPIs, GAAP to Non-GAAP, Guidance, Adjustments and more.
- Access the original source file in one click with hyperlink technology on every single data point.
- Use the data how you want it with our flexible delivery format.
Download now and get the data you need to stay ahead.
Novo Nordisk SEC Filings & Financial Statements Last 5 Years
2024 Earnings
2023 Financial Disclosures
2022 Financial Disclosures
2021 Financial Disclosures
2020 Financial Disclosures
2019 Financial Disclosures
Novo Nordisk Investor Relations Presentation
Novo Nordisk Other Documents
Novo Nordisk is a global healthcare company headquartered in Denmark, primarily focused on the development and manufacturing of pharmaceuticals for diabetes care, obesity treatment, hemophilia management, and hormone replacement therapy. The company is recognized for its innovative insulin products and GLP-1 receptor agonists, which are used to treat type 2 diabetes. Additionally, Novo Nordisk is involved in research and development of treatments for other chronic conditions, including rare blood disorders and growth hormone deficiencies.
Novo Nordisk Head of Investor Relations
The current Head of Investor Relations at Novo Nordisk is Jacob Martin Wiborg Rode. He can be contacted directly at +45 3075 5956 or via email at investor-relations@novonordisk.com
Novo Nordisk Investor Relations Email & Contact Us
For inquiries related to investor relations, stakeholders can reach out through the following contact:
Email: investor-relations@novonordisk.com
Phone: +45 3075 5956
The company encourages investors to register their email addresses via the Investor Portal to receive updates and important information
NVO Last Stock Split
Novo Nordisk executed a 2-for-1 stock split on September 20, 2023. This means that each existing share was divided into two shares, reducing the stock price proportionally while maintaining the overall market capitalization.
NVO Investor Relations Website
Novo Nordisk’s Investor Relations website provides comprehensive information for investors, including financial reports, stock performance data, and upcoming events. The portal can be accessed at Novo Nordisk Investor Portal where stakeholders can also find resources for managing their investments and contacting the company directly for any inquiries.
Covering more companies?
Create a free account to access up to 5 free data sheets.
Daloopa is your gateway to the latest data during earnings, including KPIs, guidance, GAAP to Non-GAAP and more, all formatted for immediate use.
Are you ready to stop wasting time on manual entry and start making faster, smarter decisions with accurate, up-to-date numbers you can trust? Create your free account today and get the data you need to stay ahead.
Create Free Account
About Daloopa
We believe that AI technology can improve clarity and efficiency for investors and financial markets.
Daloopa was formed in 2019, inspired by our founders’ personal experience at Point72, a NYC- based/short equiy hedge. Accurate data is central to all investment decisions and can influence speed and confidence for decision-makers. We believe that institutional finance has an opportunity to embrace tech-driven accuracy and speed.
